astemizole has been researched along with Hepatocellular Carcinoma in 3 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment with astemizole prevented diethylnitrosamine (DEN)-induced rat HCC development in vivo (followed by studying γ-glutamyl transpeptidase (GGT) activity)." | 5.42 | Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. ( Acuña-Macías, I; Camacho, J; Caro-Sánchez, CH; Chiliquinga, AJ; de Guadalupe Chávez-López, M; Díaz-Chávez, J; Gariglio, P; Hernández-Gallegos, E; Herrera, LA; Pérez-Carreón, JI; Zuñiga-García, V, 2015) |
| "The treatment with astemizole prevented diethylnitrosamine (DEN)-induced rat HCC development in vivo (followed by studying γ-glutamyl transpeptidase (GGT) activity)." | 1.42 | Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. ( Acuña-Macías, I; Camacho, J; Caro-Sánchez, CH; Chiliquinga, AJ; de Guadalupe Chávez-López, M; Díaz-Chávez, J; Gariglio, P; Hernández-Gallegos, E; Herrera, LA; Pérez-Carreón, JI; Zuñiga-García, V, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 1 |
| Wang, Y | 1 |
| Zhang, Y | 1 |
| Dang, S | 1 |
| He, S | 1 |
| de Guadalupe Chávez-López, M | 1 |
| Pérez-Carreón, JI | 1 |
| Zuñiga-García, V | 1 |
| Díaz-Chávez, J | 1 |
| Herrera, LA | 1 |
| Caro-Sánchez, CH | 1 |
| Acuña-Macías, I | 1 |
| Gariglio, P | 1 |
| Hernández-Gallegos, E | 1 |
| Chiliquinga, AJ | 1 |
| Camacho, J | 1 |
| Jeon, YJ | 1 |
| Kim, JS | 1 |
| Hwang, GH | 1 |
| Wu, Z | 1 |
| Han, HJ | 1 |
| Park, SH | 1 |
| Chang, W | 1 |
| Kim, LK | 1 |
| Lee, YM | 1 |
| Liu, KH | 1 |
| Lee, MY | 1 |
3 other studies available for astemizole and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Topics: 3' Untranslated Regions; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Astemiz | 2018 |
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.
Topics: Animals; Apoptosis; Astemizole; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Proliferation; Di | 2015 |
Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Topics: Abietanes; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Astemizole; Car | 2015 |